These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38958962)

  • 21. Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia.
    ; ; Chen AM; Erzurum SA; Chandler DL; Hercinovic A; Wu R; Vricella M; Waters AL; Ticho BH; Erickson JW; Han S; McDowell PS; Li Z; Kraker RT; Holmes JM; Cotter SA
    JAMA Ophthalmol; 2024 May; 142(5):417-428. PubMed ID: 38536764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical Atropine for Childhood Myopia Control: The Atropine Treatment Long-Term Assessment Study.
    Li Y; Yip M; Ning Y; Chung J; Toh A; Leow C; Liu N; Ting D; Schmetterer L; Saw SM; Jonas JB; Chia A; Ang M
    JAMA Ophthalmol; 2024 Jan; 142(1):15-23. PubMed ID: 38019503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
    Kothari M; Rathod V
    Indian J Ophthalmol; 2017 Nov; 65(11):1178-1181. PubMed ID: 29133646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
    Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Nakamura Y; Sotozono C; Oshika T; Morimoto T; Nishida K; Nishikawa N; Song YS; Tokutake T; Nishi Y; Shigeno Y; Kurihara T; Negishi K; Tsubota K; Ono M; Nakai T; Tan D; Tanaka S; Kinoshita S;
    Jpn J Ophthalmol; 2021 May; 65(3):315-325. PubMed ID: 33586090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report.
    Yam JC; Zhang XJ; Zhang Y; Wang YM; Tang SM; Li FF; Kam KW; Ko ST; Yip BHK; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2022 Mar; 129(3):308-321. PubMed ID: 34627809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insufficient accommodation during binocular near viewing in eyes with intermittent exotropia.
    Morimoto T; Kanda H; Hirota M; Nishida K; Fujikado T
    Jpn J Ophthalmol; 2020 Jan; 64(1):77-85. PubMed ID: 31707606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myopia progression after cessation of low-dose atropine eyedrops treatment: A two-year randomized, double-masked, placebo-controlled, cross-over trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Gan J; Bai W; Tian J; Cai Z; Yin L; Wang N
    Acta Ophthalmol; 2023 Mar; 101(2):e177-e184. PubMed ID: 35999653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.
    Zadnik K; Schulman E; Flitcroft I; Fogt JS; Blumenfeld LC; Fong TM; Lang E; Hemmati HD; Chandler SP;
    JAMA Ophthalmol; 2023 Oct; 141(10):990-999. PubMed ID: 37261839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myopia outcome study of atropine in children: Two-year result of daily 0.01% atropine in a European population.
    Loughman J; Kobia-Acquah E; Lingham G; Butler J; Loskutova E; Mackey DA; Lee SSY; Flitcroft DI
    Acta Ophthalmol; 2024 May; 102(3):e245-e256. PubMed ID: 37694816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choroidal Changes During and After Discontinuing Long-Term 0.01% Atropine Treatment for Myopia Control.
    Lee SS; Lingham G; Clark A; Read SA; Alonso-Caneiro D; Mackey DA
    Invest Ophthalmol Vis Sci; 2024 Aug; 65(10):21. PubMed ID: 39136629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Various Concentrations of Low-Dose Atropine on Pupillary Diameter and Accommodative Amplitude in Children with Myopia.
    Tran HDM; Ha TTX; Tran YH; Coroneo M; Tran TD; Truong TU; Sankaridurg P
    J Ocul Pharmacol Ther; 2024 May; 40(4):232-239. PubMed ID: 38621178
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
    Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
    BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of myopia onset with 0.025% atropine in premyopic children.
    Fang PC; Chung MY; Yu HJ; Wu PC
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing myopic error in patients with basic and convergence insufficiency intermittent exotropia in China.
    Meng Q; Wang L; Zhao M; Wu X; Guo L
    BMC Ophthalmol; 2023 Jun; 23(1):290. PubMed ID: 37365512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.
    Chia A; Lu QS; Tan D
    Ophthalmology; 2016 Feb; 123(2):391-399. PubMed ID: 26271839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
    Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P
    Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy Comparison of Repeated Low-Level Red Light and Low-Dose Atropine for Myopia Control: A Randomized Controlled Trial.
    Chen Y; Xiong R; Chen X; Zhang J; Bulloch G; Lin X; Wu X; Li J
    Transl Vis Sci Technol; 2022 Oct; 11(10):33. PubMed ID: 36269184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myopia progression and axial elongation in Spanish children: Efficacy of atropine 0.01% eye-drops.
    Moriche-Carretero M; Revilla-Amores R; Diaz-Valle D; Morales-Fernández L; Gomez-de-Liaño R
    J Fr Ophtalmol; 2021 Dec; 44(10):1499-1504. PubMed ID: 34774348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in myopia progression between dominant and non-dominant eye in patients with intermittent exotropia.
    Moon Y; Kim JH; Lim HT
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1327-1333. PubMed ID: 32307585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.